Skip to content
Recall Observatory FDA recall evidence

Drug product

Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., Saddle Brook, NJ 07863, NDC 64980-221-01

D-0573-2022

February 07, 2022

Class II

Product summary

Firm
RISING PHARMACEUTICALS
Event
Event 89545
Status
Ongoing
Classification
Class II
Quantity
2220 100-count bottles
Official record key
drug-enforcement:D-0573-2022

Official wording

Reason: Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.

Code information: lot# 25910009, Exp 01/2023

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.